litlas
ログインアカウント作成

Zigang Dong

1994–2025 年に発表

250
論文数
26,333
被引用数
99
h 指数
235
i10 指数

被引用数

Zigang Dong の年別被引用数1992 年: 被引用 1 件1994 年: 被引用 3 件1995 年: 被引用 2 件1996 年: 被引用 9 件1997 年: 被引用 28 件1998 年: 被引用 45 件1999 年: 被引用 112 件2000 年: 被引用 122 件2001 年: 被引用 177 件2002 年: 被引用 242 件2003 年: 被引用 301 件2004 年: 被引用 209 件2005 年: 被引用 233 件2006 年: 被引用 237 件2007 年: 被引用 220 件2008 年: 被引用 264 件2009 年: 被引用 215 件2010 年: 被引用 208 件2011 年: 被引用 332 件2012 年: 被引用 223 件2013 年: 被引用 198 件2014 年: 被引用 200 件2015 年: 被引用 179 件2016 年: 被引用 230 件2017 年: 被引用 181 件2018 年: 被引用 209 件2019 年: 被引用 618 件2020 年: 被引用 723 件2021 年: 被引用 779 件2022 年: 被引用 666 件2023 年: 被引用 556 件2024 年: 被引用 894 件2025 年: 被引用 478 件2026 年: 被引用 15 件1993 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,476 件、この内訳の 23.3%中国: 引用元論文 2,159 件、この内訳の 20.3%インド: 引用元論文 480 件、この内訳の 4.5%韓国: 引用元論文 441 件、この内訳の 4.2%ドイツ: 引用元論文 385 件、この内訳の 3.6%イギリス: 引用元論文 369 件、この内訳の 3.5%イタリア: 引用元論文 359 件、この内訳の 3.4%日本: 引用元論文 299 件、この内訳の 2.8%カナダ: 引用元論文 220 件、この内訳の 2.1%フランス: 引用元論文 213 件、この内訳の 2%スペイン: 引用元論文 206 件、この内訳の 1.9%オーストラリア: 引用元論文 178 件、この内訳の 1.7%
0%23.3%その他 26.7%

機関

分野

  • Biochemistry, Genetics and Molecular Biology43.5%
  • Medicine40.2%
  • Pharmacology, Toxicology and Pharmaceutics3%
  • Agricultural and Biological Sciences2.2%
  • Neuroscience2.1%
  • Immunology and Microbiology1.9%
  • その他7.1%

トピック

  • Cancer-related Molecular Pathways2.5%
  • Phytochemicals and Antioxidant Activities2.1%
  • Genomics, phytochemicals, and oxidative stress1.9%
  • Tea Polyphenols and Effects1.7%
  • RNA modifications and cancer1.7%
  • Ubiquitin and proteasome pathways1.7%
  • その他88.4%

共著者

全論文

検索で開く
  1. Targeting AURKA in Cancer: molecular mechanisms and opportunities for Cancer therapy

    著者: Ruijuan Du, Chuntian Huang, Kangdong Liu, Xiang Li, Zigang Dong - Molecular Cancer 2021 被引用: 620

  2. AKT as a Therapeutic Target for Cancer

    著者: Mengqiu Song, Ann M. Bode, Zigang Dong, Mee‐Hyun Lee - Cancer Research 2019 被引用: 804

  3. Unraveling the complexity of STAT3 in cancer: molecular understanding and drug discovery

    著者: Yamei Hu, Zigang Dong, Kangdong Liu - Journal of Experimental & Clinical Cancer Research 2024 被引用: 222

  4. Integrins in cancer: Emerging mechanisms and therapeutic opportunities

    著者: Fangfang Liu, Qiong Wu, Zigang Dong, Kangdong Liu - Pharmacology & Therapeutics 2023 被引用: 175

  5. Implications of Genetic and Epigenetic Alterations of CDKN2A (p16 INK4a ) in Cancer

    著者: Ran Zhao, Bu Young Choi, Mee-Hyun Lee, Ann M. Bode, Zigang Dong - EBioMedicine 2016 被引用: 431

  6. Ubiquitination and deubiquitination in cancer: from mechanisms to novel therapeutic approaches

    著者: Fangfang Liu, Jingyu Chen, Kai Li, Haochen Li, Yiyi Zhu, Yubo Zhai, Bingbing Lu, Yanle Fan, Ziyue Liu, Xiaojie Chen, Xuechao Jia, Zigang Dong, Kangdong Liu - Molecular Cancer 2024 被引用: 267

  7. Erianin suppresses constitutive activation of MAPK signaling pathway by inhibition of CRAF and MEK1/2

    著者: Penglei Wang, Xuechao Jia, Bingbing Lu, Han Huang, Jialin Liu, Xuejiao Liu, Qiong Wu, Yamei Hu, Pan Li, Huifang Wei, Tingting Liu, Dengyun Zhao, Lingwei Zhang, Xueli Tian, Yanan Jiang, Yan Qiao, Wenna Nie, Xinli Ma, Ruihua Bai, Cong Peng, Zigang Dong, Kangdong Liu - Signal Transduction and Targeted Therapy 2023 被引用: 93

  8. Post-translational modification of p53 in tumorigenesis

    著者: Ann M. Bode, Zigang Dong - Nature reviews. Cancer 2004 被引用: 1,256

  9. Targeting CDK12 for Cancer Therapy: Function, Mechanism, and Drug Discovery

    著者: Hui Liu, Kangdong Liu, Zigang Dong - Cancer Research 2020 被引用: 97

  10. Challenge and countermeasures for EGFR targeted therapy in non-small cell lung cancer

    著者: Xueli Tian, Tingxuan Gu, Mee‐Hyun Lee, Zigang Dong - Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2021 被引用: 141

  11. Targeting LIMK1 with luteolin inhibits the growth of lung cancer in vitro and in vivo

    著者: Man Zhang, Rui Wang, Jie Tian, Mengqiu Song, Ran Zhao, Kangdong Liu, Feng Zhu, Jung‐Hyun Shim, Zigang Dong, Mee‐Hyun Lee - Journal of Cellular and Molecular Medicine 2021 被引用: 66

  12. Molecular mechanisms of green tea polyphenols with protective effects against skin photoaging

    著者: Eunmiri Roh, Jong‐Eun Kim, Jung Yeon Kwon, Jun Seong Park, Ann M. Bode, Zigang Dong, Ki Won Lee - Critical Reviews in Food Science and Nutrition 2015 被引用: 147

  13. Cdc2-like kinases: structure, biological function and therapeutic targets for diseases

    著者: Mengqiu Song, L. Pang, Mengmeng Zhang, Yingzi Qu, Kyle Vaughn Laster, Zigang Dong - Signal Transduction and Targeted Therapy 2023 被引用: 69

  14. Protein translation: biological processes and therapeutic strategies for human diseases

    著者: Xuechao Jia, Xinyu He, Chuntian Huang, Jian Li, Zigang Dong, Kangdong Liu - Signal Transduction and Targeted Therapy 2024 被引用: 124

  15. Spatial transcriptomics analysis of esophageal squamous precancerous lesions and their progression to esophageal cancer

    著者: Xuejiao Liu, Simin Zhao, Keke Wang, Liting Zhou, Ming Jiang, Yunfeng Gao, Ran Yang, Shiwen Yan, Wen Zhang, Bingbing Lu, Fei‐Fei Liu, Ran Zhao, Wenting Liu, Zihan Zhang, Kangdong Liu, Xiang Li, Zigang Dong - Nature Communications 2023 被引用: 51

  16. Precision medicine: the foundation of future cancer therapeutics

    著者: Seung Ho Shin, Ann M. Bode, Zigang Dong - npj Precision Oncology 2017 被引用: 132

  17. Targeting AKT with costunolide suppresses the growth of colorectal cancer cells and induces apoptosis in vitro and in vivo

    著者: Hai Huang, Song Park, Haibo Zhang, Sijun Park, Wookbong Kwon, Enugyung Kim, Xiujuan Zhang, Soyoung Jang, Duhak Yoon, Seong‐Kyoon Choi, Junkoo Yi, Sung-Hyun Kim, Zigang Dong, Mee-hyun Lee, Zae Young Ryoo, Myoung Ok Kim - Journal of Experimental & Clinical Cancer Research 2021 被引用: 69

  18. Costunolide is a dual inhibitor of MEK1 and AKT1/2 that overcomes osimertinib resistance in lung cancer

    著者: Xueli Tian, Rui Wang, Tingxuan Gu, Fayang Ma, Kyle Vaughn Laster, Xiang Li, Kangdong Liu, Mee‐Hyun Lee, Zigang Dong - Molecular Cancer 2022 被引用: 58

  19. The Role of PGC1α in Cancer Metabolism and its Therapeutic Implications

    著者: Zheqiong Tan, Xiangjian Luo, Lanbo Xiao, Min Tang, Ann M. Bode, Zigang Dong, Ya Cao - Molecular Cancer Therapeutics 2016 被引用: 188

  20. Toxic Phytochemicals and Their Potential Risks for Human Cancer

    著者: Ann M. Bode, Zigang Dong - Cancer Prevention Research 2014 被引用: 141

  21. PI3K/Akt/mTOR Signaling Pathway: Role in Esophageal Squamous Cell Carcinoma, Regulatory Mechanisms and Opportunities for Targeted Therapy

    著者: Qian Luo, Ruijuan Du, Wenting Liu, Guojing Huang, Zigang Dong, Xiang Li - Frontiers in Oncology 2022 被引用: 97

  22. Repurposed pizotifen malate targeting NRF2 exhibits anti-tumor activity through inducing ferroptosis in esophageal squamous cell carcinoma

    著者: Xinyu He, Yubing Zhou, Wenjing Chen, Xiaokun Zhao, Lina Duan, Hao Zhou, Mingzhu Li, Yu Yin, Jimin Zhao, Yaping Guo, Huihui Gu, Yanan Jiang, Zigang Dong, Kangdong Liu - Oncogene 2023 被引用: 42

  23. Circulating Tumor Cells: Moving Biological Insights into Detection

    著者: Lichan Chen, Ann M. Bode, Zigang Dong - Theranostics 2017 被引用: 133

  24. Inflammation in cancer: therapeutic opportunities from new insights

    著者: Yifei Xie, Fangfang Liu, Yunfei Wu, Yuer Zhu, Yanan Jiang, Qiong Wu, Zigang Dong, Kangdong Liu - Molecular Cancer 2025 被引用: 93